Interestingly, MDMs treated with either Furin inhibitor I, or neutralizing anti-TGF-β antibodies, at the time and following HIV-1 infection expressed significantly less surface CD91/LRP-1 as compared to untreated cells (Figure 9B). Here, FURIN is linked to HIV-1 infection.